Literature DB >> 12487962

[Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].

J Campdelacreu1, E Muñoz, A Cervera, S Jaumà, M Girós, E Tolosa.   

Abstract

Cerebrotendinous xanthomatosis (CTX) is a genetic disorder caused by a 27-hydroxilase enzyme deficiency, leading to beta-cholestanol storage in many body tissues. Clinically, the disease is characterised by the presence of tendinous xanthomas, juvenile cataracts and progressive neurologic dysfunction. The diagnosis requires beta-cholestanol quantification in serum. We report two siblings with a history of photosensitive epilepsy of childhood onset, who developed progressive spastic paraparesis and cataracts in their third decade of life. They were diagnosed to have CTX in spite of the absence of tendinous xanthomas. Cranial and spinal MRI only showed bilateral high intensity signal in the dentate nuclei in the T2-weighted and proton-density sequences. Our patients presented with a progressive spastic paraparesis. The delay in the diagnosis in our case could be due to the absence of tendinous xanthomas and late-onset cataracts. The recognition of the disease is important, because the treatment with chenodeoxycholic acid induces a decrement of beta-cholestanol levels in serum and could prevent the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487962

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  4 in total

1.  Cerebrotendinous xanthomatosis: neuropathological findings.

Authors:  B Pilo de la Fuente; I Ruiz; A Lopez de Munain; A Jimenez-Escrig
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

2.  Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis.

Authors:  Paola Caroppo; Federico D'Agata; Andrea Mignarri; Maria Laura Stromillo; Maria Teresa Dotti; Tiziana Mongini
Journal:  Neurol Sci       Date:  2012-12-05       Impact factor: 3.307

3.  Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.

Authors:  A Mignarri; S Rossi; M Ballerini; G N Gallus; M Del Puppo; P Galluzzi; A Federico; M T Dotti
Journal:  J Neurol       Date:  2010-11-21       Impact factor: 4.849

4.  Spinal cerebrotendinous xanthomatosis: A case report and literature review.

Authors:  Isis Atallah; Diego San Millán; Wicki Benoît; Belinda Campos-Xavier; Andrea Superti-Furga; Christel Tran
Journal:  Mol Genet Metab Rep       Date:  2021-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.